# XERIS PHARMACEUTICALS INC — Form D

XERIS PHARMACEUTICALS INC of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2017-05-22. The offering totals $45.0M, of which $30.1M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2017-05-22
- Form: D
- Accession: 0001346302-17-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $45.0M
- Amount sold: $30.1M
- Remaining: $14.9M
- Investors: 22
- Date of first sale: 2017-05-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-287198

## Issuer

- Name: XERIS PHARMACEUTICALS INC
- CIK: 0001346302
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3925 WEST BRAKER LANE, AUSTIN, TX, 78759
- Phone: 512-534-8340

## Officers, directors & promoters (23)

| Name | Role | Location |
| --- | --- | --- |
| Paul Edick | Director | Chicago, IL |
| Robert Faulker | Director | Chicago, IL |
| Cary McNair | Director | Houston, TX |
| Navneet Puri | Director | Bridgewater, NJ |
| Jonathan Rigby | Director | Mississauga, A6 |
| Paul Edick | Executive Officer | Chicago, IL |
| Brad Huckabee | Executive Officer | Chicago, IL |
| John Shannon | Executive Officer | Burnsville, MN |
| Phillip Johnson | Executive Officer | Austin, TX |
| TIMOTHY SULLIVAN | Director | Austin, TX |
| Douglas Baum | Director | Austin, TX |
| Douglas Baum | Executive Officer | Austin, TX |
| Poul Strange | Executive Officer | Austin, TX |
| Steven Prestrelski | Director | Austin, TX |
| Steven Prestrelski | Executive Officer | Austin, TX |
| Yash Sabharwal | Executive Officer | Austin, TX |
| John Kinzell | Director | Austin, TX |
| John Kinzell | Executive Officer | Austin, TX |
| Shane Brisbin | Director | Austin, TX |
| Doug Baum | Director | Austin, TX |
| John Kinzel | Director | Austin, TX |
| John Kinzel | Executive Officer | Austin, TX |
| Mark Saliman | Executive Officer | Austin, TX |

## Other filings by this issuer (9)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2016-12-30](https://search.stillhousedata.com/formd/0001346302-16-000002) | D/A | $50.0M | $45.0M |
| [2016-01-11](https://search.stillhousedata.com/formd/0001346302-16-000001) | D | $50.0M | $41.0M |
| [2014-09-29](https://search.stillhousedata.com/formd/0001346302-14-000001) | D | $14.9M | $7.3M |
| [2013-07-10](https://search.stillhousedata.com/formd/0001346302-13-000002) | D/A | $3.0M | $2.3M |
| [2013-02-14](https://search.stillhousedata.com/formd/0001346302-13-000001) | D/A | $3.0M | $1.8M |
| [2012-09-25](https://search.stillhousedata.com/formd/0001346302-12-000002) | D/A | $3.0M | $1.1M |
| [2012-06-08](https://search.stillhousedata.com/formd/0001346302-12-000001) | D | $3.0M | $225K |
| [2011-10-12](https://search.stillhousedata.com/formd/0001346302-11-000006) | D/A | $2.0M | $1.8M |
| [2011-07-19](https://search.stillhousedata.com/formd/0001346302-11-000005) | D | $2.0M | $1.3M |

## More

- [CIK 1346302 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1346302&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001346302-17-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.